118 related articles for article (PubMed ID: 34959645)
1. Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37.
Zhang Y; Lakshmaiah Narayana J; Wu Q; Dang X; Wang G
Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959645
[TBL] [Abstract][Full Text] [Related]
2. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
Wang G; Mishra B; Epand RF; Epand RM
Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
[TBL] [Abstract][Full Text] [Related]
3. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.
Wang G
J Biol Chem; 2008 Nov; 283(47):32637-43. PubMed ID: 18818205
[TBL] [Abstract][Full Text] [Related]
4. Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.
Wang G; Narayana JL; Mishra B; Zhang Y; Wang F; Wang C; Zarena D; Lushnikova T; Wang X
Adv Exp Med Biol; 2019; 1117():215-240. PubMed ID: 30980360
[TBL] [Abstract][Full Text] [Related]
5. Peptide Stability Is Important but Not a General Requirement for Antimicrobial and Antibiofilm Activity In Vitro and In Vivo.
Decker AP; Su Y; Mishra B; Verma A; Lushnikova T; Xie J; Wang G
Mol Pharm; 2023 Jan; 20(1):738-749. PubMed ID: 36485036
[TBL] [Abstract][Full Text] [Related]
6. Anti-Staphylococcal Biofilm Effects of Human Cathelicidin Peptides.
Mishra B; Golla RM; Lau K; Lushnikova T; Wang G
ACS Med Chem Lett; 2016 Jan; 7(1):117-21. PubMed ID: 26819677
[TBL] [Abstract][Full Text] [Related]
7. Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents.
Tzitzilis A; Boura-Theodorou A; Michail V; Papadopoulos S; Krikorian D; Lekka ME; Koukkou AI; Sakarellos-Daitsiotis M; Panou-Pomonis E
J Pept Sci; 2020 Jul; 26(7):e3254. PubMed ID: 32567085
[TBL] [Abstract][Full Text] [Related]
8. Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.
Wang G; Elliott M; Cogen AL; Ezell EL; Gallo RL; Hancock RE
Biochemistry; 2012 Jan; 51(2):653-64. PubMed ID: 22185690
[TBL] [Abstract][Full Text] [Related]
9. Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensis.
Blower RJ; Barksdale SM; van Hoek ML
PLoS Negl Trop Dis; 2015; 9(7):e0003862. PubMed ID: 26196513
[TBL] [Abstract][Full Text] [Related]
10. On-resin cleavage of bacterially expressed fusion proteins for purification of active recombinant peptides SK-29, KR-20, LL-29, and LL-23 from human sweat or skin.
Li Y; Li X; Wang G
Protein Expr Purif; 2007 Oct; 55(2):395-405. PubMed ID: 17590350
[TBL] [Abstract][Full Text] [Related]
11. Structural remodeling and oligomerization of human cathelicidin on membranes suggest fibril-like structures as active species.
Sancho-Vaello E; François P; Bonetti EJ; Lilie H; Finger S; Gil-Ortiz F; Gil-Carton D; Zeth K
Sci Rep; 2017 Nov; 7(1):15371. PubMed ID: 29133814
[TBL] [Abstract][Full Text] [Related]
12. Structural location determines functional roles of the basic amino acids of KR-12, the smallest antimicrobial peptide from human cathelicidin LL-37.
Mishra B; Epand RF; Epand RM; Wang G
RSC Adv; 2013 Nov; (42):. PubMed ID: 24307932
[TBL] [Abstract][Full Text] [Related]
13. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.
Li X; Li Y; Han H; Miller DW; Wang G
J Am Chem Soc; 2006 May; 128(17):5776-85. PubMed ID: 16637646
[TBL] [Abstract][Full Text] [Related]
14. Amino Acid Composition Determines Peptide Activity Spectrum and Hot-Spot-Based Design of Merecidin.
Wang X; Mishra B; Lushnikova T; Narayana JL; Wang G
Adv Biosyst; 2018 May; 2(5):. PubMed ID: 30800727
[TBL] [Abstract][Full Text] [Related]
15. Design and characterization of a new hybrid peptide from LL-37 and BMAP-27.
Al Tall Y; Abualhaijaa A; Alsaggar M; Almaaytah A; Masadeh M; Alzoubi KH
Infect Drug Resist; 2019; 12():1035-1045. PubMed ID: 31118709
[No Abstract] [Full Text] [Related]
16. Individual and Combined Effects of Engineered Peptides and Antibiotics on Pseudomonas aeruginosa Biofilms.
Mishra B; Wang G
Pharmaceuticals (Basel); 2017 Jun; 10(3):. PubMed ID: 28672834
[No Abstract] [Full Text] [Related]
17. Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37.
Krishnamoorthy R; Adhikari P; Anaikutti P
RSC Adv; 2023 May; 13(23):15594-15605. PubMed ID: 37228679
[TBL] [Abstract][Full Text] [Related]
18. The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs.
Kuroda K; Okumura K; Isogai H; Isogai E
Front Oncol; 2015; 5():144. PubMed ID: 26175965
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the core fragments of the LL-37 host defense peptide with actin.
Sol A; Wang G; Blotnick E; Golla R; Bachrach G; Muhlrad A
RSC Adv; 2015; 5(13):9361-9367. PubMed ID: 26726303
[TBL] [Abstract][Full Text] [Related]
20. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function.
Oren Z; Shai Y
Biochemistry; 2000 May; 39(20):6103-14. PubMed ID: 10821683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
